Skip to main content

Thyroid function testing in neonates born to women with hypothyroidism

Abstract

Our aim was to assess the utility of serum thyroxine and thyroid stimulating hormone performed at 10–14 days of life in diagnosing congenital hypothyroidism (CH) in babies born to mothers with hypothyroidism. This was a retrospective study of all babies born in a tertiary referral centre for neonatology over a 12-month period. Infants who had thyroid function testing (TFT) checked at 10–14 days of life because of maternal hypothyroidism during the period of study were included. The results of the newborn bloodspot and day 10–14 TFT were recorded along with whether or not patients were subsequently treated. Of the 319 patients included in the study, only two patients were found to have CH and in both cases the newborn blood spot had been abnormal.

Conclusion: No extra cases of CH were detected from the thyroid test at 10–14 days and this practice should be discontinued due to the robust nature of existing newborn screening programmes.

What is Known:
Congenital hypothyroidism(CH) is the commonest preventable cause of childhood intellectual impairment.
Family history of hypothyroidism has been implicated as a risk factor for CH.
CH has formed part of newborn screening since the 1970s.
What is New:
There is no research recommending thyroid function testing at 10–14 days of life to detect CH in neonates born to mothers with hypothyroidism.
Thyroid function testing at 10–14 days of life does not improve diagnostic yield for CH in babies born to mothers with hypothyroidism.
Newborn blood spot remains the mainstay for accurate and timely diagnosis of CH.

This is a preview of subscription content, access via your institution.

Abbreviations

(CH):

Congenital hypothyroidism

(TFT):

Thyroid function testing

(T4):

Thyroxine

(TSH):

Thyroid stimulating hormone

References

  1. A practical guide to newborn bloodspot screening in Ireland. Health service executive, Ireland (2012). Available at: http://www.hse.ie/eng/health/child/newbornscreening/newbornbloodspotscreening/Information_for_Professionals/. Date accessed: 12/10/2014

  2. Dalili S, Rezvany SM, Dadashi A, Medghalchi A, Mohammadi H, Dalili H, Mirzanejad M, Gholamnezhad H, Amirhakimi A (2012) Congenital hypothyroidism: a review of the risk factors. Acta Med Iran 50(11):735–739

    PubMed  Google Scholar 

  3. Girling J, Sykes L (2013) Thyroid disorders and other endocrinological disorders in pregnancy. Obstet, Gynaecol Reprod Med 23(6):171–179

    Article  Google Scholar 

  4. Habeb AM, Zubier M, Pairaudeau P, Mathew V (2003) Do we need to assess the thyroid function in the infants of mothers with Hashimoto’s thyroiditis. Arch Dis Child Fetal Neonatal Ed 88(3):F258

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. Kempers MJ, Lanting CI, van Heijst AF, van Trotsenburg ASP, Wiedijk BM, de Vijlder JJM, Vulsma T (2006) Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin, and thyroxine-binding globulin measurement: potentials and pitfalls. J Clin Endocrinol Metab 91(9):3370–3376

    CAS  Article  PubMed  Google Scholar 

  6. LaFranchi S (1999) Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid 9(7):735–740

    CAS  Article  PubMed  Google Scholar 

  7. Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, Polak M, Butler G (2014) European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab 99(2):363–384

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lott JA, Sardovia-Iyer M, Speakman KS, Lee KK (2004) Age-dependent cutoff values in screening newborns for hypothyroidism. Clin Biochem 37(9):791–797

    CAS  Article  PubMed  Google Scholar 

  9. Medda E, Olivieri A, Stazi MA, Grandolfo ME, Fazzini C, Baserga M, Burroni M, Cacciari E, Calaciura F, Cassio A, Chiovato L, Costa P, Leonardi D, Martucci M, Moschini L, Pagliardini S, Parlato G, Pignero A, Pinchera A, Sala D, Sava L, Stoppioni V, Tancredi F, Valentini F, Vigneri R, Sorcini M (2005) Risk factors for congenital hypothyroidism: results of a population case-control study (1997–2003). Eur J Endocrinol 153(6):765–773

    CAS  Article  PubMed  Google Scholar 

  10. Ogilvy-Stuart AL (2002) Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed 87(3):F165–F171

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. Ogundele MO, Waterson M (2010) When should we be conducting thyroid function tests in newborns and young infants? Arch Dis Child 95(2):151–152

    Article  PubMed  Google Scholar 

  12. Olney RS, Grosse SD, Vogt RF Jr (2010) Prevalence of congenital hypothyroidism—current trends and future directions: workshop summary. Pediatrics 125(Suppl 2):S31–S36

    Article  PubMed  Google Scholar 

  13. Rose SR, Brown RS, Wilkins L, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, Varma SK (2006) Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 117:2290

    Article  PubMed  Google Scholar 

  14. Rovet J, Daneman D (2003) Congenital hypothyroidism: a review of current diagnostic and treatment practices in relation to neuropsychologic outcome. Pediatr Drugs 5(3):141–149

    Article  Google Scholar 

  15. Simpser T, Rapaport R (2010) Update on some aspects of neonatal thyroid disease. J Clin Res Pediatr Endocrinol 2(3):95–99

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wikner BN, Sparre LS, Stiller CO, Kallen B, Asker C (2008) Maternal use of thyroid hormones in pregnancy and neonatal outcome. Acta Obstet Gynecol Scand 87(6):617–627

    Article  PubMed  Google Scholar 

Download references

Authors’ Contributions

All authors were involved in the design and planning of the research performed. M. McGovern was the primary investigator and performed the majority of data collection, analysis and presentation of data. Z. Reyani conducted data collection regarding newborn screening and reviewed this article before submission. P. O’Connor was involved in the design of the study and supervised data collection and analysis. M. White was involved in the design of the study and supervised data collection and analysis. J. Miletin was the overall project co-ordinator and oversaw all aspects of the project.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Matthew McGovern.

Ethics declarations

Funding

This study received no funding of any type.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. As this study formed part of a departmental audit with regard to neonatal thyroid function testing formal ethical approval for access to patient records was not obtained from the departmental ethics board.

Informed consent

For this type of study formal consent is not required.

Additional information

Communicated by Patrick Van Reempts

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

McGovern, M., Reyani, Z., O’Connor, P. et al. Thyroid function testing in neonates born to women with hypothyroidism. Eur J Pediatr 175, 2015–2018 (2016). https://doi.org/10.1007/s00431-016-2793-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-016-2793-8

Keywords

  • Congenital hypothyroidism
  • Thyroid function tests
  • Infant
  • Newborn
  • Risk factors
  • Neonatal screening